Pharmacies - Asia

  • Asia
  • The Pharmacies market in Asia is expected to experience significant growth in the coming years.
  • According to projections, the revenue in this market is estimated to reach a staggering €471.00bn by 2024.
  • This growth is expected to continue at an annual growth rate of 4.92% from 2024 to 2029, resulting in a market volume of €598.80bn by the end of 2029.
  • When compared to other countries around Worldwide, United States is expected to generate the highest revenue in the Pharmacies market, with an estimated revenue of €355.40bn in 2024.
  • This highlights the significant market potential and dominance of the United States in this industry.
  • In terms of per person revenues, the Pharmacies market is projected to generate approximately €103.60 per person in Asia in 2024.
  • This indicates the significant contribution of the Pharmacies market sector to the overall economy and its importance in providing healthcare services to the population.
  • In Japan, pharmacies are seeing a rise in demand for traditional herbal remedies and natural supplements.

Key regions: United States, China, Germany, Japan, Europe

 
Mercado
 
Región
 
Comparación de regiones
 
Moneda
 

Analyst Opinion

The Pharmacies market in Asia has been experiencing significant growth in recent years. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors all contribute to this development. Customer preferences in the Pharmacies market in Asia have shifted towards a greater emphasis on health and wellness. With an increasing awareness of the importance of preventive healthcare, consumers are seeking out pharmacies that offer a wide range of products and services to support their overall well-being. This includes not only prescription medications, but also over-the-counter drugs, vitamins and supplements, personal care products, and health monitoring devices. In addition, customers are also looking for pharmacies that provide personalized advice and guidance on managing their health conditions. One of the key trends in the Pharmacies market in Asia is the expansion of pharmacy chains. As economies in the region continue to grow, there is a rising demand for accessible and affordable healthcare services. Pharmacy chains are able to meet this demand by establishing a network of stores in strategic locations, offering a wide range of products and services, and leveraging economies of scale to keep prices competitive. This trend is particularly evident in countries like China and India, where the population is large and the healthcare infrastructure is still developing. Another trend in the market is the increasing adoption of e-commerce. Online pharmacies are becoming more popular in Asia, as they offer convenience and a wider range of products compared to traditional brick-and-mortar stores. Customers can easily browse and purchase medications and healthcare products from the comfort of their own homes, and have them delivered directly to their doorstep. This trend is driven by factors such as the growing penetration of smartphones and internet connectivity, as well as the rising preference for contactless shopping experiences. Local special circumstances also play a role in shaping the Pharmacies market in Asia. For example, in countries like Japan and South Korea, where the population is aging rapidly, there is a growing demand for pharmacies that cater to the specific healthcare needs of older adults. These pharmacies may offer specialized products and services, such as medication management systems and home healthcare equipment, to support the elderly population in maintaining their health and independence. Underlying macroeconomic factors also contribute to the development of the Pharmacies market in Asia. Rapid urbanization, population growth, and increasing disposable incomes are driving the demand for healthcare products and services. Additionally, government initiatives to improve access to healthcare and promote preventive healthcare practices are also fueling the growth of the market. For example, in countries like Singapore and Thailand, the government has implemented policies to encourage the establishment of community pharmacies and promote the use of generic medications, in order to make healthcare more affordable and accessible to the population. In conclusion, the Pharmacies market in Asia is experiencing growth due to customer preferences for health and wellness, the expansion of pharmacy chains, the increasing adoption of e-commerce, local special circumstances, and underlying macroeconomic factors. These factors are driving the demand for a wide range of healthcare products and services, and shaping the market landscape in different countries in the region.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Visión general

  • Revenue
  • Users
  • Volume
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Espere, por favor

Contacto

¿Alguna duda? Estaremos encantados de atenderte.
Statista Locations
Contacto Nerea Marcos
Nerea Marcos
Client Success Manager

Lu - vi, 9:30 - 17:00 h (CET)

Contacto Meredith Alda
Meredith Alda
Sales Manager– Contacto (Estados Unidos)

Lu - vi, 9:00 - 18:00 h (EST)

Contacto Yolanda Mega
Yolanda Mega
Operations Manager– Contacto (Asia)

Lu - vi, 9:00 - 17:00 h (SGT)

Contacto Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contacto (Asia)

Lu - vi, 10:00 - 18:00 h (JST)

Contacto Lodovica Biagi
Lodovica Biagi
Director of Operations– Contacto (Europa)

Lu - vi, 9:30 - 17:00 h (GMT)

Contacto Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contacto (América Latina)

Lu - vi, 9:00am-6:00pm (EST)